Annual Report 2022-2023

Transfers to the NSLHD As the official fundraising partner for the NSLHD, the funds we receive are transferred directly to our beneficiaries meaning that our hospital staff, clinicians and other healthcare staff are able to determine how best to use the funds to improve our patient services or expand our research programs. This financial year saw a 128% increase in funds transferred to the NSLHD. Increased distribution of funds in FY23 was mainly derived from bequest income received by the NORTH Foundation. $8,043,000 in contributions to hospitals, staff, projects and researchers

Total tied and untied funding ‘Untied funding’ is where a donation is made and the cause has not been specified. It includes funding where the hospital or research institute has been specified, but not the actual cause and as a result, these funds are often used for the beneficiaries’ highest priorities. ‘Tied or semi-tied funding’ is where the specific department, cause, clinician, researcher or project has been specified by the donor and therefore the funds can only be used for this purpose.

Top 10 tied funded causes *inclusive of bequest income

Cancer

$977,278

ICU

$588,993

Emergency

$10 million tied funds $1 million untied funds

$497,067

Renal

$442,317

Aged care

$339,165 Vector borne diseases $301,500

Investment in research In FY23, our generous donors chose to give $7.2 million to life-changing research projects. These gifts provided crucial funding for initiatives aimed at translating research into clinical practice, creating early detection mechanisms, discovering new treatment options and improving outcomes for patients.

Dermatology $187,854

Cardiology

$124,956

Hospice

$106,859

$7.2 million for research

Mental health $105,121

9

Made with FlippingBook Digital Proposal Creator